Seeking Alpha

BioCryst Pharmaceuticals Inc. (BCRX)

()

News & PR
Market Currents

Buzz
Twitter: BCRX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

BioCryst: H1N1 Antiviral Partner Gets Fast Tracked for Japanese Review

Dec 9 • Michael Murphy • 9 Comments
BioCryst's Korean Partner Receives Emergency Use Authorization

Dec 9 • Michael Murphy • 17 Comments
Short Blood Supply Means Long Outlook for Cerus

Nov 15 • Michael Shulman • 2 Comments
Thursday Options Recap

Nov 12 • Frederic Ruffy • 1 Comment
Why Has Cel-Sci Quietly Amended Some Previously Filed Paperwork?

Nov 12 • M. E. Garza • 14 Comments
Wall Street Breakfast: Must-Know News

Oct 29 • SA Editor Eli Hoffmann • 15 Comments
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?

Oct 29 • Mike Havrilla • 1 Comment
Tuesday Options Recap

Oct 27 • Frederic Ruffy • Comment!
Equities Update: Oil Drops, Stocks Too

Oct 26 • Midnight Trader • 4 Comments
Monday Options Recap

Oct 26 • Frederic Ruffy • Comment!
Wall Street Breakfast: Must-Know News

Oct 26 • SA Editor Eli Hoffmann • 14 Comments
Friday's Options Recap

Oct 16 • Frederic Ruffy • 3 Comments
Movers and Shakers Include Flu Stocks Sinovac and BioCryst Pharma

Oct 14 • M. E. Garza • 4 Comments
Swine Flu Stocks: Where Are They Now?

Oct 2 • Everyday Finance • 11 Comments
Surviving Wednesday's Wild Ride in Healthcare and Biotech

Oct 1 • M. E. Garza • 1 Comment
Onyx Pharmaceuticals: Nexavar Promising for Metastatic Breast Cancer

Sep 23 • Prohost Biotech • 1 Comment
Options Trader Monday Outlook: Microbe Mania

Sep 21 • Philip Davis • 9 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Closing Update: Dow's 0.6% Advance Leads the Way

Sep 15 • Midnight Trader • 5 Comments
BioCryst Jumps on Flu Drug Deal

Sep 15 • optionMONSTER • Comment!
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Megatrend Companies Summary

Sep 10 • Bryan Gomez • 12 Comments
Friday Options Recap

Sep 4 • Frederic Ruffy • 2 Comments
A Guide to Investing in the Next Decade

Aug 27 • Bryan Gomez • 2 Comments
Increased Interest in Cel-Sci After Latest SEC Filing

Aug 26 • M. E. Garza • 12 Comments
Closing Update for Tuesday, August 25: Dow Makes It Six Straight Gains

Aug 25 • Midnight Trader • 9 Comments
Stocks with 10x Gain Since March: Room to Run?

Aug 25 • Dr. Kris • 4 Comments
Wall Street Breakfast: Must-Know News

Jul 30 • SA Editor Rachael Granby • 16 Comments
Swine Flu Stocks - Just Wait Until Fall

Jul 29 • Everyday Finance • 29 Comments
Swine Flu Vaccines Will Have to Wait

Jul 14 • David White • 4 Comments
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index

Jul 1 • M. E. Garza • Comment!
Companies Involved in the Treatment of Swine Flu

Jun 17 • Kaushik Paul • 11 Comments
A Biotech Triple Play: Dendreon, BioCryst and Arena

May 25 • Michael Murphy • 28 Comments
How the U.S. Profits From Swine Flu

May 19 • Jesse Veverka • 2 Comments
Swine Flu: A Follow-Up on 'Trading the Hype'

May 4 • Mike Stathis • Comment!
Swine Flu: Trade Smartly, Beware the Hype

Apr 30 • Mike Stathis • 23 Comments
Swine Flu Stock Watchlist

Apr 30 • Babak • 5 Comments
5 Potential Pandemic Shorts

Apr 29 • Michael Shulman • 4 Comments
Tuesday's Options Recap

Apr 28 • Frederic Ruffy • Comment!
The Swine Flu Effect

Apr 28 • Carol Flake Chapman • 25 Comments
Beneficiaries and Losers from the Swine Flu Scare

Apr 28 • Matthew D. McCall • 4 Comments

BioCryst Pharmaceuticals Inc. (BCRX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers